Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor β
- 15 July 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 50 (4) , 899-908
- https://doi.org/10.1016/s0360-3016(01)01524-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Redox-mediated activation of latent transforming growth factor-beta 1Molecular Endocrinology, 1996
- Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the TumorAnnals of Surgery, 1995
- Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβThe British Journal of Radiology, 1995
- Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast CancerNew England Journal of Medicine, 1993
- The long term outcome after radical radiotherapy for advanced localized non-small cell carcinoma of the lungClinical Oncology, 1993
- Transforming growth factor-beta in disease: the dark side of tissue repair.Journal of Clinical Investigation, 1992
- Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular CarcinomaJapanese Journal of Cancer Research, 1992
- TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequencesCell, 1990
- Clinical dose-response curves of human malignant epithelial tumoursThe British Journal of Radiology, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958